Angiographic adjuvant

Details Angiographic adjuvant Angiographic adjuvant

1994-10-19

1995-08-29

Robinson, Allen J.

Drug, bio-affecting and body treating compositions

In vivo diagnosis or in vivo testing

X-ray contrast imaging agent

514573, 514783, 514786, 514929, 514974, 514975, 424 91, A01N 2502, A01N 3708, A61K 4900, A61K 4904

Patent

active

054458129

ABSTRACT:
An angiographic adjuvant comprising a fat emulsion containing a compound having prostaglandin E1 activities, and an angiographic method using the adjuvant.

REFERENCES:
patent: 4493847 (1985-01-01), Mizushima et al.
patent: 4820732 (1989-04-01), Shell et al.
patent: 4880634 (1989-11-01), Speiser
patent: 4955878 (1990-09-01), See et al.
patent: 5064636 (1991-11-01), Li et al.
patent: 5120527 (1992-06-01), Li et al.
patent: 5124352 (1992-06-01), Mizushima et al.
K. Korosue et al.; Clinical Effects of Lipo Prostaglandin E1 in Patients with Delayed Cerebral Vasospasm; STN File Server; (Kalsruhe) File Medline; Jun. 15, 1987, pp. 635-640.
Partial European Search Report, Application No. EP 90 30 7268.4 (1991).

Affiliated with

Also associated with

Rating

Angiographic adjuvant does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Angiographic adjuvant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiographic adjuvant will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1818272